Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation

Clinical trial NCT07267949 · RECRUITING

Trial details

NCT number: NCT07267949
Sponsor: Acesion Pharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atrial Fibrillation (AF)

Start date: 2025-10-22
Primary completion: 2026-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.